Eureka Therapeutics and City of Hope treat first patient with GPC3 targeting ARTEMIS® T cells (ECT204) for advanced liver cancer
EMERYVILLE, Calif., and LOS ANGELES, May 31, 2022 - Eureka Therapeutics Inc., a clinical-stage biotechnology company developing novel T cell therapies to treat solid tumors,...